期刊文献+

微量免疫荧光标记法检测冠心病患者血清肺炎衣原体抗体 被引量:2

Determination of specific-antibodies against chlamydia pneumoniae by indirect microimmunofluorescence test
下载PDF
导出
摘要 目的 测定冠心病患者的血清肺炎衣原体特异性抗体 ,探讨其临床价值。方法 应用间接微量免疫荧光标记法对 2 0 5例体检健康人群和 170例住院确诊的冠心病患者进行肺炎衣原体特异性抗体 Ig G、Ig M的检测。结果 体检健康人群 Ig G总阳性率 2 1.5 % ;均阴性 ;冠心病患者 Ig G总阳性率为 91.2 % ,Ig M阳性率为 5 % ,其中无症状型冠心病组、不稳定型心绞痛组及急性心肌梗死组肺炎衣原体总感染率分别为 96 .2 %、86 %、88.1% ,既往感染率分别为 76 .9%、6 2 .0 %、71.4 % ,急性感染率分别为 19.2 %、2 4 .0 %、16 .7%。总感染率、既往感染率及急性感染率冠心病组较健康人群组明显增高 (优势比分别为 4 .14、2 .88、19.2 4 ,95 %的可信区间分别为 3.18~ 5 .39、2 .2 1~ 3.74、2 .79~ 132 .6 7)。结论 微量免疫荧光标记法系目前冠心病患者血清检测肺炎衣原体特异性抗体 ,从而确定肺炎衣原体感染的一个敏感度高、特异性强 ,简单易行的方法之一。 Objective Infection with chlamydia pneumoniae has been postulated to play a pathogenic role in atherosclerosis and coronary heart diseases.To investigate the relation between chlamydia pneumoniae infection and serum levels of species specific IgG and IgM.Methods Species specific serum antibodies to chlamydia pneumoniae were measured using indirect microimmunofluorescence test in 205 normal healthing subjects(control) and 170 patients with coronary heart diseases(CHD),including 78 cases of latent coronary heart diseases(LCHD),50 of unstable angina(UAP) and 42 of acute myocardial infarction(AMI).2ml of venous blood was collected in sterile tubes .Serum was frozen in -80℃ refrigeration.Results The total IgG positive rates were 21.5% and 91.2% in control and CHD groups. There is no IgM positive in control but there were 5% in CHD group. The total infection positive rates ,the previous infection rates and the acute infection rates were significantly higher in CHD group than in the Control group.Odds Ratio for the development of CHD were 4.14,2.88,19.24,(95% CI 3.18 to 5.39,2.21to 3.74,2.79 to132.67). Conclusion Chlamydia pneumoniae infection rate significantly increase in patients with LCHD,UAP and AMI which may play a important role.The Determination of specific-antibodies against chlamydia pneumoniae by indirect microimmunofluorescence test woule be helpful to the study of this CHD infection.
出处 《中国心血管杂志》 2004年第3期202-204,共3页 Chinese Journal of Cardiovascular Medicine
基金 20 0 0年深圳市卫生科技计划项目编号 :2 0 0 0 0 40 13
关键词 肺炎衣原体 微量免疫荧光检测 种特异性抗体 冠心病 Chlamydia pneumoniae Microimmunofluorescence test Species specific-antibodies Coronary heart diseases
  • 相关文献

参考文献6

  • 1Boman J, Hammerschlag MR. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies [J]. Clin Microbiol Rev, 2002,15 : 1-20.
  • 2rayston JT, Ruoce, Campbell LA, et al. Chlamydia pneumoniae SP, Nora for chlamydia SP, Strain TWAR[J]. Int JSys Bacterial, 1989,39:88-90.
  • 3Chuo CC, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumoniae in an altherosclerotic lesions of coronary arteries [J]. J Infect Dis, 1993,167:841-849.
  • 4Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chamydia pneumoniae,strain TWAR [J]. JInfect Dis, 1990,181:s427-425.
  • 5倪安平,王辉,董平,李永哲,王仲,朱元珏.肺炎、支气管炎和急性上呼吸道感染患者肺炎衣原体感染的研究[J].中华内科杂志,1995,34(6):388-391. 被引量:45
  • 6Danesh J, Collins R, Peto R, et al. Chronic and coronary heart disease: is there a link? [J]. Lancet, 1997,350:430-436.

二级参考文献2

  • 1倪安平,中华医学杂志,1994年,74卷,416页
  • 2Wang S P,J Clin Microbiol,1979年,10卷,259页

共引文献44

同被引文献29

  • 1刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:789
  • 2Jokinen C, Heiskanen L, Juvonen H, et al. Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland[J]. Clin Infect Dis, 2001,32(8):1141-1154.
  • 3Lagerstrom F, Bader M, Foldevi M, et al. Microbiological etiology in clinically diagnosed community-acquired pneumonia in primary care in Orebro, Sweden[J]. Clin Microbiol Infect, 2003,9 (7) : 645-652.
  • 4Sopena N, Sabria M, Pedro-Botet ML, et al. Prospective study of community-acquired pneumonia of bacterial etiology in adults[J]. Eur J Clin Microbiol Infect Dis, 1999,18(12) :852-858.
  • 5Persson K, Boman J. Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae[J]. Clin Diagn Lab Immunol, 2000,7(5):739-744.
  • 6Koh WP, Taylor MB, Hughes K, et al. Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese,Malays and Asian Indians in Singapore[J]. Int J Epidemiol, 2002,31 (5):1001-1007.
  • 7Tuuminen T, Varjo S, Ingman H, et al. Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays[J]. Clin Diagn Lab Immunol, 2000,7(5) :734-738.
  • 8Lin TM, Kuo CC, Chen WJ, et al. Seroprevalence of Chlamydia pneumoniae infection in Taiwan [J]. J Infect, 2004,48(1) :91-95.
  • 9Ni AP,Lin GY, Yang L, et al. A seroepidemiologic study of Chlamydia pneumoniae, Chlamydia trachomatis and Chlamydia psittaci in different populations on the mainland of China[J]. Scand J Infect Dis, 1996,28(6) :553-557.
  • 10Paltiel O, Kark JD, Leinonen M, et al. High prevalence of antibodies to Chlamydia pneumoniae;determinants of lgG and IgA seropositivity among Jerusalem residents[J]. Epidemiol Infect, 1995,114 (3) : 465-473.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部